The latest Pharmaceutical and Healthcare disease pipeline guide Allergic conjunctivitis - Pipeline Review, H1 2017, provides an overview of the Allergic conjunctivitis (conjunctiva) pipeline landscape.
Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander or other allergy-causing substances. Symptoms include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye and stringy eye discharge. Treatment includes antihistamine or anti-inflammatory medication.
The Pharmaceutical and Healthcare latest pipeline guide Allergic Conjunctivitis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The latest Market report as pipeline guide for Allergic Conjunctivitis - Pipeline Review, H1 2017, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape. The Key Company Profiles are Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, AlleCures Inc, Allergan Plc, Clevexel Pharma SAS, Griffin Discoveries BV, NicOx SA, Ocular Therapeutix Inc, Ohr Pharmaceutical Inc, Portola Pharmaceuticals Inc, Re-Pharm Ltd, Realm Therapeutics Plc and Sylentis SAU, Xencor Inc.
Get Discount on this Research Report at http://www.rnrmarketresearch.com/contacts/discount?rname=1010189 – This report is available at up to 25% Discount till June 02nd 2017.
The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III and Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 3, 2, 10 and 1 respectively.
Allergic Conjunctivitis (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Inquire more on this Research Report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1010189
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Allergic Conjunctivitis (Ophthalmology).
The pipeline guide reviews pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Allergic Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Allergic Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology)
Purchase this research report Direct from http://www.rnrmarketresearch.com/contacts/purchase?rname=1010189 .
Table of Contents:
Global Markets Direct Report Coverage
Allergic Conjunctivitis - Overview
Allergic Conjunctivitis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Allergic Conjunctivitis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Allergic Conjunctivitis - Companies Involved in Therapeutics Development
Allergic Conjunctivitis - Drug Profiles
Allergic Conjunctivitis - Dormant Projects
Allergic Conjunctivitis - Discontinued Products
Allergic Conjunctivitis - Product Development Milestones

List of Tables.
Number of Products under Development for Allergic Conjunctivitis, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Allergic Conjunctivitis - Pipeline by Accolade Pharmaceuticals LLC, H1 2017
Allergic Conjunctivitis - Pipeline by Aldeyra Therapeutics Inc, H1 2017
Allergic Conjunctivitis - Pipeline by AlleCures Inc, H1 2017
Allergic Conjunctivitis - Pipeline by NicOx SA, H1 2017
Allergic Conjunctivitis - Pipeline by Ocular Therapeutix Inc, H1 2017
Allergic Conjunctivitis - Pipeline by Ohr Pharmaceutical Inc, H1 2017
Allergic Conjunctivitis - Pipeline by Realm Therapeutics Plc, H1 2017
Allergic Conjunctivitis - Pipeline by Sylentis SAU, H1 2017
Allergic Conjunctivitis - Pipeline by Xencor Inc, H1 2017
Allergic Conjunctivitis - Dormant Projects, H1 2017
Allergic Conjunctivitis - Discontinued Products, H1 2017
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an [email protected] with Global Construction Industry in subject line and your contact details.